Investigación Translacional do Doente Critico. Mecanismo de lesión celular
Lesión celular do paciente crítico
Institute of Clinical and Experimental Medicine
Praga, República ChecaPublikationen in Zusammenarbeit mit Forschern von Institute of Clinical and Experimental Medicine (3)
2020
-
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22
2016
-
Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper
International Journal of Cardiology, Vol. 222, pp. 303-312
2015
-
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion
International Journal of Cardiology, Vol. 184, Núm. 1, pp. 323-336